Morton's neuroma is a benign formation that occurs in the area of the interdigital nerves of the foot, most often between the third and fourth toes. This disease causes painful sensations, burning and discomfort when walking, which is associated with compression of the nerve and the development of neuroma - an increase in the diameter of the nerve fiber. Morton's neuroma can manifest itself with symptoms that significantly worsen the quality of life of patients, leading to a limitation of physical activity. The pathogenetic mechanisms of neuroma are not fully understood, but it is known that repeated microexacerbations and mechanical damage to the nerve play a key role in the development of this disease.
History of the disease and interesting historical facts
Morton's neuroma was first described in medical literature in the mid-19th century. Dr. D. Morton, after whom this syndrome is named, was one of the first to draw attention to the manifestations of this disease and describe its clinical features. Since then, neuroma has become the subject of intensive study in orthopedics and podiatry. The direction of treatment and diagnostics has also evolved significantly: from simple methods, such as the use of orthopedic insoles, to complex surgical interventions. Interestingly, at the end of the 20th century, studies aimed at studying neuromas showed that this disease is often associated with excessive physical activity and improper footwear.
Epidemiology
Morton's neuroma affects 5-10% of the population, but the actual incidence may be higher due to under-reporting. The disease is most often diagnosed in women aged 25 to 50 years, which is due to the peculiarities of shoe choice and foot anatomy. Statistics show that almost 70% patients have symptoms of both types of neuroma, which may indicate their predisposition to this disease. Moreover, gender differences and the influence of various factors may have a significant impact on the incidence among different ethnic groups.
Genetic predisposition to this disease
To date, no specific genes have been identified that directly link Morton's neuroma to a genetic predisposition. However, a number of studies point to possible mutations that may affect the elasticity of connective tissues. The main molecules involved in the pathogenesis are associated with the regulation of collagen and other structural proteins. Moreover, genetic variants that affect nerve sensitivity may increase susceptibility to compression and the development of neuromas.
Risk factors for the development of this disease
There are many risk factors that contribute to the development of Morton's neuroma. The main ones include:
- Incorrect shoes, especially narrow ones and high heels
- Excessive physical activity and monotonous movements
- Anatomical features of the foot, such as flat feet or high arches
- Injuries or chronic compression of the foot
- Sports activities that require standing or walking for many hours
These factors appear to contribute to the development of neuroma through repeated trauma and compression of the interdigital nerve.
Diagnosis of this disease
Diagnosis of Morton's neuroma involves a comprehensive approach, which includes the following steps:
- Clinical examination based on history taking and symptoms such as burning, discomfort and local pain
- Laboratory tests to rule out other diseases
- Radiological tests, such as ultrasound or MRI, to visualize the tumor
- Conducting special tests such as the interdigital nerve compression test
- Differential diagnosis, which includes exclusion of neuritis and other benign formations
The main focus is on identifying characteristic symptoms that help the doctor make an accurate diagnosis.
Treatment
Treatment of Morton's neuroma can be divided into several approaches:
- General treatment, which includes changing footwear and reducing physical activity
- Pharmacological treatment, using nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain and inflammation
- Surgical treatment, which is used when conservative methods are ineffective and includes removal of the neuroma
- Other treatments, including physical therapy and steroid injections, to reduce inflammation and improve the condition
The combination of these methods can significantly improve the patient's quality of life and reduce symptoms.
List of medications used to treat this disease
The main drugs used to treat Morton's neuroma include:
- Ibuprofen
- Naproxen
- diclofenac
- Ketorolac
- Injectable corticosteroids
These medications can be used to both relieve pain and reduce inflammation.
Disease monitoring
Monitoring of the patient's condition includes regular examinations to assess the effectiveness of treatment and the dynamics of the disease. The prognosis for patients with Morton's neuroma is usually favorable, provided that the treatment is correct and timely. However, possible complications, such as relapses of the disease or the development of chronic pain, can significantly complicate the clinical picture.
Age-related features of the disease
Morton's neuroma has its own specifics depending on the patient's age. In young people, the disease may manifest itself in the form of acute symptoms and respond well to treatment. At the same time, in older patients, the disease may be more resistant to therapy and associated with other foot diseases, which makes it difficult to influence the course of the disease.
Questions and Answers
- What are the main symptoms of Morton's neuroma? The main symptoms include burning, pain in the area between the toes, discomfort when walking and a “tingling” sensation.
- Is it possible to treat neuroma without surgery? Yes, many cases can be successfully treated with conservative methods, including changing footwear and using medications.
- What is the chance of recurrence after surgery? Recurrence occurs in approximately 10-20% cases, especially if risk factors persist.
- How long has Morton's neuroma been known? The disease was first described in the mid-19th century, making it one of the longest-studied diseases in orthopedics.
- Who is more susceptible to the disease? The main risk group is women aged 25 to 50 years, especially those who wear tight shoes or actively participate in sports.
